These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 34068120)

  • 1. Metabolic Response of Triple-Negative Breast Cancer to Folate Restriction.
    Coleman MF; O'Flanagan CH; Pfeil AJ; Chen X; Pearce JB; Sumner S; Krupenko SA; Hursting SD
    Nutrients; 2021 May; 13(5):. PubMed ID: 34068120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Reprogramming by Folate Restriction Leads to a Less Aggressive Cancer Phenotype.
    Ashkavand Z; O'Flanagan C; Hennig M; Du X; Hursting SD; Krupenko SA
    Mol Cancer Res; 2017 Feb; 15(2):189-200. PubMed ID: 28108628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of folic acid withdrawal on transcriptomic profiles in murine triple-negative breast cancer cell lines.
    Kok DE; O'Flanagan CH; Coleman MF; Ashkavand Z; Hursting SD; Krupenko SA
    Biochimie; 2020 Jun; 173():114-122. PubMed ID: 32304770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF13 promotes metastasis of triple-negative breast cancer.
    Johnstone CN; Pattison AD; Harrison PF; Powell DR; Lock P; Ernst M; Anderson RL; Beilharz TH
    Int J Cancer; 2020 Jul; 147(1):230-243. PubMed ID: 31957002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Selection of Intermediately- and Highly-Malignant Variants of Triple-negative Breast Cancer in Orthotopic Nude Mouse Models.
    Yano S; Takehara K; Kishimoto H; Tazawa H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
    Anticancer Res; 2016 Dec; 36(12):6273-6277. PubMed ID: 27919946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of 3PO analog PFK15 and siPFKL efficiently suppresses the migration, colony formation ability, and PFK-1 activity of triple-negative breast cancers by reducing the glycolysis.
    Kashyap A; Umar SM; Dev J R A; Mathur SR; Gogia A; Batra A; Deo SVS; Prasad CP
    J Cell Biochem; 2023 Sep; 124(9):1259-1272. PubMed ID: 37450687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cantharidin Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing Autophagy and Inducing Apoptosis in Vitro and in Vivo.
    Li HC; Xia ZH; Chen YF; Yang F; Feng W; Cai H; Mei Y; Jiang YM; Xu K; Feng DX
    Cell Physiol Biochem; 2017; 43(5):1829-1840. PubMed ID: 29050003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of triple-negative breast cancer preclinical models provides functional evidence of metastatic progression.
    Arroyo-Crespo JJ; Armiñán A; Charbonnier D; Deladriere C; Palomino-Schätzlein M; Lamas-Domingo R; Forteza J; Pineda-Lucena A; Vicent MJ
    Int J Cancer; 2019 Oct; 145(8):2267-2281. PubMed ID: 30860605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of Polymer-Based Drug Delivery Vehicles Targeting Folate Receptors in Triple-Negative Breast Cancer.
    Das D; Koirala N; Li X; Khan N; Dong F; Zhang W; Mulay P; Shrikhande G; Puskas J; Drazba J; McLennan G
    J Vasc Interv Radiol; 2020 Nov; 31(11):1866-1873.e2. PubMed ID: 33129432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic properties, glycolytic effects and high-resolution respirometry mitochondrial activities of Eriocephalus racemosus against MDA-MB 231 triple-negative breast cancer.
    Adu-Amankwaah F; Februarie C; Nyambo K; Maarman G; Tshililo N; Mabasa L; Mavumengwana V; Baatjies L
    BMC Complement Med Ther; 2024 Sep; 24(1):332. PubMed ID: 39256791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive proteomics and sialiomics of the anti-proliferative activity of safranal on triple negative MDA-MB-231 breast cancer cell lines.
    Zarrineh M; Ashrafian S; Jensen P; Nawrocki A; Ansari AM; Rezadoost H; Ghassempour A; Larsen MR
    J Proteomics; 2022 May; 259():104539. PubMed ID: 35240313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BETi enhance ATGL expression and its lipase activity to exert their antitumoral effects in triple-negative breast cancer (TNBC) cells.
    Rossi T; Zamponi R; Chirico M; Pisanu ME; Iorio E; Torricelli F; Gugnoni M; Ciarrocchi A; Pistoni M
    J Exp Clin Cancer Res; 2023 Jan; 42(1):7. PubMed ID: 36604676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocan as a prognostic biomarker of triple-negative breast cancer.
    Sagara A; Igarashi K; Otsuka M; Kodama A; Yamashita M; Sugiura R; Karasawa T; Arakawa K; Narita M; Kuzumaki N; Narita M; Kato Y
    Breast Cancer Res Treat; 2017 Jan; 161(2):269-278. PubMed ID: 27888420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat.
    Tate CR; Rhodes LV; Segar HC; Driver JL; Pounder FN; Burow ME; Collins-Burow BM
    Breast Cancer Res; 2012 May; 14(3):R79. PubMed ID: 22613095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low Dose of Paclitaxel Combined with XAV939 Attenuates Metastasis, Angiogenesis and Growth in Breast Cancer by Suppressing Wnt Signaling.
    Shetti D; Zhang B; Fan C; Mo C; Lee BH; Wei K
    Cells; 2019 Aug; 8(8):. PubMed ID: 31416135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer.
    Xiang L; Gilkes DM; Chaturvedi P; Luo W; Hu H; Takano N; Liang H; Semenza GL
    J Mol Med (Berl); 2014 Feb; 92(2):151-64. PubMed ID: 24248265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer.
    Noblejas-López MDM; Nieto-Jimenez C; Burgos M; Gómez-Juárez M; Montero JC; Esparís-Ogando A; Pandiella A; Galán-Moya EM; Ocaña A
    J Exp Clin Cancer Res; 2019 Aug; 38(1):383. PubMed ID: 31470872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
    Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
    Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted exosome-encapsulated erastin induced ferroptosis in triple negative breast cancer cells.
    Yu M; Gai C; Li Z; Ding D; Zheng J; Zhang W; Lv S; Li W
    Cancer Sci; 2019 Oct; 110(10):3173-3182. PubMed ID: 31464035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic Acid-Functionalized Carbon Dot-Enabled Starvation Therapy in Synergism with Paclitaxel against Breast Cancer.
    Ghosh A; Ghosh AK; Chowdhury M; Das PK
    ACS Appl Bio Mater; 2022 May; 5(5):2389-2402. PubMed ID: 35452214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.